AstraZeneca Inks $555M AI-CRISPR Deal with Algen to Target Immunology
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.
#ImmunologyTherapies
Explore AIstify's latest reporting, research, and expert analysis tagged with "immunology therapies", collected in one continuously updated archive.
Related Posts